Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Wulignan A1 exhibits activity against leukemia P-388 in vitro; it also may have anti-influenza virus H1N1 and H1N1-TR (a Tamiflu drug resistant virus strain) activities.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 550.00 | |
1 mL * 10 mM (in DMSO) | Inquiry | $ 570.00 |
Description | Wulignan A1 exhibits activity against leukemia P-388 in vitro; it also may have anti-influenza virus H1N1 and H1N1-TR (a Tamiflu drug resistant virus strain) activities. |
In vitro | Four new lignan compounds named Wulignan A1 (4), A 2(5), epiWulignan A1 (6) and epischisandrone(7), and three known lignan compounds, enshicine(1), epienshicine(2) and schisandrone(3), were isolated from the fruits of Schisandra henryi Clarke collected in the district of Yibin, Sichuan Province[1] |
Source |
Molecular Weight | 342.39 |
Formula | C20H22O5 |
CAS No. | 117047-76-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Wulignan A1 117047-76-4 Microbiology/Virology Antifection Wulignan A-1 inhibitor inhibit